Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2739-2743

  Crisosto, Nicolás ^a   Codner, Ethel ^a   Maliqueo, Manuel ^a   Echiburú, Bárbara ^a   Sánchez, Fernando ^a   Cassorla, Fernando ^a   Sir Petermann, Teresa ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; SEX HORMONE;

ADOLESCENT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; TESTOSTERONE BLOOD LEVEL;

EID: 34447136826     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0267     Document Type: Article

References (42)

1. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
2. Holte J 1996 Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 10:221-247
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
4. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
5. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type II diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
6. O'Meara NM, Blackman JD, Ehrmann DA 1993 Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1241-1247
7. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P 2000 Premature adrenarchenormal variant or forerunner of adult disease? Endocr Rev 21:671-696
8. Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A, Vicens-Calvet E 1993 Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1599-1603
9. DiMartino-Nardi J 2000 Pre- and postpuberal findings in premature adrenarche. J Pediatr Endocrinol Metab 13(Suppl 5):1265-1269
10. Rosenfield RL 1990 Hyperandrogenism in peripubertal girls. In: Mahoney CP, ed. Current issues in pediatric and adolescent endocrinology. Philadelphia: Saunders; 1333-1358
11. Franks S 2002 Adult polycystic ovary syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab 16:263-272
12. Homburg R, Lambalk C 2004 Polycystic ovary syndrome in adolescence - a therapeutic conundrum. Hum Reprod 19:1039-1042
13. Witchel SF 2006 Puberty and polycystic ovary syndrome. Mol Cell Endocrinol 254-255:146-153
14. Cate RL, Mattaliano RJ, Heisson C, Tizard R, Farber NM, Cheung A 1986 Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685-698
15. Josso N, di Clemente N 1999 TGF-B family members and gonadal development. Trends Endocrinol Metab 10:216-222
16. Lee MM, Donahoe PK 1993 Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
17. Josso N, Cate RL, Picard JY, Vigier B, di Clemente N, Wilson C, Imbeaud S, Pepinsky RB, Guerrier D, Boussin L, Legeai L, Carré-Eusebe D 1993 Anti-Mullerian hormone: the Jost factor. Recent Prog Horm Res 48:1-59
18. Josso N, Lamarre I, Picard JY, Berta P, Davies N, Morichon N, Peschanski M, Jeny R 1993 Anti-Mullerian hormone in early human development. Early Hum Dev 33:91-99
19. Josso N, Racine C, di Clemente N, Rey R, Xavier F 1998 The role of anti-Mullerian hormone in gonadal development. Mol Cell Endocrinol 145:3-7
20. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE 1999 Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84:3836-3844
21. Cook CL, Siow Y, Taylor S, Fallat ME 2000 Serum Mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73:859-861
22. Rey RA, Lhomme C, Marcillac I, Lahlou N, Duvillard P, Josso N, Bidart JM 1996 Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum α-inhibin and estradiol. Am J Obstet Gynecol 174:958-965
23. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT 1996 Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81:571-576
24. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77:357-362
25. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D 2003 Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88:5957-5962
26. Laven JS, Mulders AG, Visser JA, Themmen APN, DeJong FH, Fauser BC 2004 Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89:318-323
27. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS 2005 Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20:1820-1826
28. Sir-Petermann T, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, Crisosto N, Perez-Bravo F, Recabarren SE, Cassorla F 2006 Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:3105-3109
29. Zawadski JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
30. Adams J, Polson DW, Franks S 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293:355-359
31. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL 2002 Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60
32. Rey RA, Codner E, Iniguez G, Bedecarras P, Trigo R, Okuma C, Gottlieb S, Bergada I, Campo SM, Cassorla FG 2005 Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias. J Clin Endocrinol Metab 90:6035-6040
33. Ibañez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A 1997 Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 82:2283-2288
34. Ibañez L, Ferrer A, Ong K, Amin R, Dunger D, de Zegher F 2004 Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr 144:23-29
35. Lewy VD, Danadian K, Witchel SF, Arslanian S 2001 Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 138:38-44
36. La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V 2004 Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril 82:970-972
37. Golden SH, Ding J, Szkio M, Schmidt MI, Duncan BB, Dobs A 2004 Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160:540-548
38. Cooper HE, Spellacy WN, Prem KA, Cohen WD 1968 Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol 100:371-387
39. Givens JR 1988 Familial polycystic ovarian disease. Endocrinol Metab Clin North Am 17:771-783
40. Ferriman D, Purdie AW 1979 The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 11:291-300
41. Hague WM, Adams J, Reeders ST, Peto TE, Jacobs HS 1988 Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) 29:593-605
42. Lunde O, Magnus P, Sandvik L, Hoglo S 1989 Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 28:23-30